Plain-English translation of NCT05094843 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lung Cancer research guide →This study is looking at what happens to your heart during and after minimally invasive lung cancer surgery. Researchers will use heart monitoring (electrocardiograms) and blood tests to measure changes in your heart's electrical activity and signs of heart stress. The goal is to understand these changes better and figure out if they affect how well patients recover after surgery.
Lung cancer surgery can affect the heart and cause temporary changes in heart rhythm and function, but these changes haven't been studied in detail with modern minimally invasive surgical techniques. This research will help doctors understand these changes better and predict which patients might have complications.
You likely qualify if…
You likely don't qualify if…
You would have heart electrical tracings (ECGs) recorded before surgery, daily after surgery, and at a follow-up visit two weeks later. During surgery and recovery, continuous heart monitoring will occur. You'll also have blood tests taken before and after surgery to measure heart stress markers. The study involves standard monitoring and testing—no experimental medications or procedures beyond what's typical for lung cancer surgery.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
Finland
Enrollment target
~100 participants
Started
March 2022
Primary completion
December 2028
Age range
18 Years and older
Last updated on clinicaltrials.gov in September 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jahangir A Khan, MD, PhD
MD, PhD
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.